The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately estimate tumour size in patients with a type of breast cancer called ductal carcinoma in situ (DCIS). The main question it aims to answer is: Can FCI accurately estimate DCIS lesion size compared with histology results? Participants will have a standard MRI scan and an FCI scan before undergoing surgery to remove the tumour.
Study Type
OBSERVATIONAL
Enrollment
12
Baseline FCI scan
Baseline MRI scan
University of Aberdeen
Aberdeen, United Kingdom
Accuracy of DCIS lesion size estimation using FCI, validated against histopathological measurements (gold standard).
Extent of agreement between lesion size estimation by FCI and actual lesion size according to NHS histopathology results.
Time frame: Baseline
Comparison of DCIS lesion measurements using FCI and 3T MRI.
Extent of agreement in lesion size measurements between FCI and conventional 3T MRI.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.